WASHINGTON - The U.S. House of Representatives on Thursday passed dramatic reforms to the patent law that supporters say will clarify how patent holders should be selected, limit frivolous lawsuits and streamline the patent application process.
Minnesota companies built on their own innovation say the revisions are critical as they pursue profits through invention. St. Paul-based 3M, which holds 7,000 U.S. patents and 40,000 patents worldwide, spent tens of thousands of dollars lobbying for the patent bill's passage.
"We do a billion dollars of research and development each year," said Kevin Rhodes, the vice president in charge of intellectual property at 3M. "We want to be a technology leader. It was time for an update."
The House bill allows a patent to go to the first inventor to file for one, not necessarily the first person who discovered a concept or device. Further, lawsuits for incorrect patent markings will be limited to those whose businesses would actually be hurt by those bad markings. Currently, anyone who finds bad markings, such as an expired or incorrect patent number, may sue.
The markings issue has led to a surge of unnecessary litigation, according to proponents of the patent bill, including Minnesota's St. Jude Medical Inc. and Boston Scientific. Marking lawsuits grew from one in 2006 to 674 in 2010, several businesses said in a letter supporting the reforms. Companies who get sued "face huge liability for mass-produced products," the group noted.
The House also agreed to hold patent fees in a special account, not the general fund, so the fees can be used to speed up the patent approval and review process. The legislation, approved 304-117, is similar to a bill already passed by the Senate and blessed by the White House.
A broad range of metro-area companies applauded the legislation, including medical-device maker Medtronic Inc. and Cargill, the giant international food producer. "Cargill believes in a strong global patent system that rewards innovation; parts of the [old] system created expense and ambiguity," said Dan Enebo, the company's chief intellectual property counsel. The Patent and Trademark Office (PTO) has a backlog of 1.2 million patent requests, three times what it was a decade ago, Rhodes said. Delays in patent approvals hurt inventors trying to protect their intellectual property, while keeping inventors from finding investors to get their discoveries to market, he said.
Fridley-based medical device maker Medtronic, which spent $1.5 billion on research and development in fiscal year 2011, said the U.S. Patent & Trademark Office lacks the resources to process patent applications efficiently. "This prevents new technologies, and the jobs that would result, from reaching the marketplace and benefitting the economy," the company said in a statement.